Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay in Subjects Suspected of Having Bladder Cancer

NCT05643690 is registered in ClinicalTrials.gov with AnchorDx Medical Co. Ltd. US as lead sponsor.

NCT NCT05643690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05643690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay in Subjects Suspected of Having Bladder Cancer
Lead sponsor
AnchorDx Medical Co. Ltd. US
Phase
Observational
Overall status
Suspended
Start date
November 18, 2022
Completion date
December 31, 2025
Enrollment
77 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer